Showing 61-75 of 118 results
Health Lab
A potential drug candidate called ONC201 nearly doubled survival for patients with diffuse midline glioma and DIPG.
Department News
Dr. Campbell defended his dissertation
Health Lab
A study from the University of Michigan Rogel Cancer Center uncovers a new mechanism to explain why some prostate tumors switch from a common, treatable form to a more rare and aggressive form of prostate cancer.
Health Lab
A study from clinicians and researchers at the University of Michigan Rogel Cancer Center reveals findings from over 800 clinical assays performed for kidney patients with MiTF family gene mutations.
Department News
M&I actively seeks diversity and inclusion with the U-M Summer Research Opportunities Program (SROP)
Health Lab
A pediatric cancer patient received new 3D metallic ribs from Spain to help treat and manage her disease.
Department News
Aric Brown will defend his dissertation
Department News
M&I is pleased to announce the creation of the A. Oveta Fuller Memorial Award Fund.
Department News
Andrew W. Tai, MD, PhD, has been appointed assistant dean for early medical education in the Medical School
Health Lab
Physicians, nurse practitioners, social workers, spiritual care professionals, clinical pharmacists and other specialized providers all work together to create a unified palliative care team at Michigan Medicine.
Department News
Pat Schloss and Will Fitzsimmons receive 2023 EBS Awards
Health Lab
An analysis finds that up to millions of dollars could be saved annually on cancer immunotherapy treatments across the Veterans Health Administration by reconsidering how those drugs are delivered.
Department News
Tomoyuki Murakami promoted to Research Assistant Professor
Health Lab
After an awake surgery to remove a cancerous brain tumor, a Michigan man is living “more deliberately” than ever — officiating a high school wrestling state championship and participating in research for a potential cure.
Health Lab
Research, led by Michigan Medicine and the University of Michigan, suggests that glioblastoma cells are poised near a “critical point” of order and disorder — meaning, the cells possess some form of large-scale coordination throughout the whole tumor that allows them to respond in practical unison to attempts to kill tumor cells, such as chemotherapy or radiation.